Cargando…

RT-PCR detection of respiratory pathogens in newborn children admitted to a neonatal medium care unit

BACKGROUND: This study aimed to determine the prevalence of respiratory pathogens among newborns admitted to a neonatal medium care unit (NMCU) and to identify clinical predictors. METHODS: A 1-y observational study was performed of neonates admitted to an NMCU in Amsterdam, The Netherlands. Nasopha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Smit, Patrick M., Pronk, Suzanne M., Kaandorp, Jos C., Weijer, Olivier, Lauw, Fanny N., Smits, Paul H.M., Claas, Eric C.J., Mulder, Jan W., Beijnen, Jos H., Brandjes, Dees P.M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group US 2012
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7086686/ https://www.ncbi.nlm.nih.gov/pubmed/23202720 http://dx.doi.org/10.1038/pr.2012.176

Ejemplares similares

Adult outpatient experience of the 2009 H1N1 pandemic: Clinical course, pathogens, and evaluation of case definitions
por: Smit, Patrick M., et al.
Publicado: (2011)

Procalcitonin in children with suspected novel influenza A (H1N1) infection
por: Limper, Maarten, et al.
Publicado: (2010)

Clinical practice of hepatitis B screening in patients starting with chemotherapy: A survey among Dutch oncologists
por: Leber, Karin, et al.
Publicado: (2021)

Ethnic differences in cardiometabolic risk profile in an overweight/obese paediatric cohort in the Netherlands: a cross-sectional study
por: van Vliet, Mariska, et al.
Publicado: (2009)

Cardiometabolic risk variables in overweight and obese children: a worldwide comparison
por: van Vliet, Mariska, et al.
Publicado: (2011)

Genetic glucocorticoid receptor variants differ between ethnic groups but do not explain variation in age of diabetes onset, metabolic and inflammation parameters in patients with type 2 diabetes
por: Ahdi, Mohamed, et al.
Publicado: (2023)

Gait dynamics to optimize fall risk assessment in geriatric patients admitted to an outpatient diagnostic clinic
por: Kikkert, Lisette H. J., et al.
Publicado: (2017)

ABCB1 genotypes and haplotypes in patients with dementia and age-matched non-demented control patients
por: Frankfort, Suzanne V, et al.
Publicado: (2006)

Treatment Individualization in Colorectal Cancer
por: van Geel, Robin M. J. M., et al.
Publicado: (2015)

Review of Chromatographic Bioanalytical Assays for the Quantitative Determination of Marine-Derived Drugs for Cancer Treatment
por: van Andel, Lotte, et al.
Publicado: (2018)

Differential impact of impaired fasting glucose versus impaired glucose tolerance on cardiometabolic risk factors in multi-ethnic overweight/obese children
por: van Vliet, Mariska, et al.
Publicado: (2010)

Long-term platinum retention after treatment with cisplatin and oxaliplatin
por: Brouwers, Elke EM, et al.
Publicado: (2008)

Validation of a liquid chromatographic method for the pharmaceutical quality control of products containing elacridar()
por: Sawicki, Emilia, et al.
Publicado: (2016)

Comparing the old and new generation SELDI-TOF MS: implications for serum protein profiling
por: Gast, Marie-Christine W, et al.
Publicado: (2008)

Dengue disease severity in Indonesian children: an evaluation of the World Health Organization classification system
por: Setiati, Tatty E, et al.
Publicado: (2007)

Practical Recommendations for Therapeutic Drug Monitoring of Kinase Inhibitors in Oncology
por: Verheijen, Remy B., et al.
Publicado: (2017)

Pharmacokinetics of Selected Anticancer Drugs in Elderly Cancer Patients: Focus on Breast Cancer
por: Crombag, Marie-Rose B.S., et al.
Publicado: (2016)

Protein versus DNA as a marker for peripheral blood mononuclear cell counting
por: Jansen, Robert S., et al.
Publicado: (2009)

P-gp and taxanes
por: Hendrikx, Jeroen J.M.A., et al.
Publicado: (2014)

Stable Isotopically Labeled Intravenous Microdose Pharmacokinetic Trials as a Tool to Assess Absolute Bioavailability: Feasibility and Paradigm to Apply for Protein Kinase Inhibitors in Oncology
por: Roosendaal, Jeroen, et al.
Publicado: (2020)

Combining Isotopic Tracer Techniques to Increase Efficiency of Clinical Pharmacokinetic Trials in Oncology
por: Roosendaal, Jeroen, et al.
Publicado: (2020)

Intracellular Pharmacokinetics of Pyrimidine Analogues used in Oncology and the Correlation with Drug Action
por: Derissen, Ellen J. B., et al.
Publicado: (2020)

Detection of Colorectal Cancer by Serum and Tissue Protein Profiling: A Prospective Study in a Population at Risk
por: Engwegen, Judith Y.M.N., et al.
Publicado: (2008)

Overweight children with type 1 diabetes have a more favourable lipid profile than overweight non-diabetic children
por: van Vliet, Mariska, et al.
Publicado: (2011)

Fixed Dosing of Monoclonal Antibodies in Oncology
por: Hendrikx, Jeroen J.M.A., et al.
Publicado: (2017)

The Mechanism-Based Inactivation of CYP3A4 by Ritonavir: What Mechanism?
por: Loos, Nancy H. C., et al.
Publicado: (2022)

The inhibitory and inducing effects of ritonavir on hepatic and intestinal CYP3A and other drug-handling proteins
por: Loos, Nancy H.C., et al.
Publicado: (2023)

Is Bodyweight-Based Dosing Truly Better Than Flat Dosing for Panitumumab? [Letter]
por: Hendrikx, Jeroen J M A, et al.
Publicado: (2020)

Palladium‐induced granulomas analysed with inductively coupled plasma mass spectrometry
por: Marsidi, Nick, et al.
Publicado: (2018)

Intracranial antitumor responses of nivolumab and ipilimumab: a pharmacodynamic and pharmacokinetic perspective, a scoping systematic review
por: van Bussel, Mark T. J., et al.
Publicado: (2019)

Representativeness of Phase III Trial for Osimertinib in Pretreated Advanced EGFR-Mutated Non-small-cell Lung Cancer Patients and Treatment Outcomes in Clinical Practice
por: Lin, Lishi, et al.
Publicado: (2021)

Pharmacokinetics and Toxicities of Oral Docetaxel Formulations Co-Administered with Ritonavir in Phase I Trials
por: Vermunt, Marit, et al.
Publicado: (2021)

Specific Investigation of Sample Handling Effects on Protease Activities and Absolute Serum Concentrations of Various Putative Peptidome Cancer Biomarkers
por: van den Broek, Irene, et al.
Publicado: (2010)

Clinical Pharmacokinetics of Systemically Administered Antileishmanial Drugs
por: Kip, Anke E., et al.
Publicado: (2017)

Bioanalytical assay for the quantification of the tyrosine kinase inhibitor EAI045 and its major metabolite PIA in mouse plasma and tissue homogenates using liquid chromatography–tandem mass spectrometry
por: Susam, M. Merve, et al.
Publicado: (2022)

Influenza infection and risk of acute pulmonary embolism
por: van Wissen, Matthijs, et al.
Publicado: (2007)

The Association of Medication-Use and Frailty-Related Factors with Gait Performance in Older Patients
por: de Groot, Maartje H., et al.
Publicado: (2016)

Systematic Review of Host-Mediated Activity of Miltefosine in Leishmaniasis through Immunomodulation
por: Palić, Semra, et al.
Publicado: (2019)

Two-stage model-based design of cancer phase I dose escalation trials: evaluation using the phase I program of barasertib (AZD1152)
por: Keizer, Ron J., et al.
Publicado: (2011)

Clinical Pharmacokinetics and Pharmacodynamics of Pazopanib: Towards Optimized Dosing
por: Verheijen, Remy B., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_tg1fbu6h72f7vtfsf3ffqr8kh0